MedTrace Logo

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

NCT02752997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-04-27

No results posted yet for this study

Summary

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Conditions

Interventions

OTHER

Pharmacist discharge medication services

Included in arm descriptions

Sponsors & Collaborators

Principal Investigators

  • Sarah R Lessard, Pharm.D. · Mayo Clinic Health System - Franciscan Healthcare

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02752997 on ClinicalTrials.gov